Cargando…
(212)Pb α-Radioimmunotherapy Targeting CD38 in Multiple Myeloma: A Preclinical Study
Multiple myeloma (MM) is a plasma cell cancer and represents the second most frequent hematologic malignancy. Despite new treatments and protocols, including high-dose chemotherapy associated with autologous stem cell transplantation, the prognosis of MM patients is still poor. α-radioimmunotherapy...
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Society of Nuclear Medicine
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7383085/ https://www.ncbi.nlm.nih.gov/pubmed/31862796 http://dx.doi.org/10.2967/jnumed.119.239491 |